HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,502,699 | -0.5% | 128,407 | -5.5% | 0.34% | +8.9% |
| Q2 2023 | $11,563,885 | -7.3% | 135,822 | -9.9% | 0.32% | -12.5% |
| Q1 2023 | $12,474,149 | +118848.7% | 150,745 | +13.1% | 0.36% | +9.4% |
| Q4 2022 | $10,487 | -99.9% | 133,339 | -11.3% | 0.33% | -8.6% |
| Q3 2022 | $11,129,000 | -3.7% | 150,330 | -15.3% | 0.36% | +3.2% |
| Q2 2022 | $11,562,000 | +3.0% | 177,385 | -0.1% | 0.35% | +31.2% |
| Q1 2022 | $11,224,000 | +11.0% | 177,540 | -6.9% | 0.27% | +31.0% |
| Q4 2021 | $10,113,000 | -22.6% | 190,675 | +3.0% | 0.20% | -25.1% |
| Q3 2021 | $13,071,000 | -6.0% | 185,168 | -11.2% | 0.27% | +8.8% |
| Q2 2021 | $13,899,000 | – | 208,566 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |